Some nuclear startups are funding their long road to commercial power by selling offshoot products—from life sciences to supercomputing cables. (Axios)
TerraPower, founded by Bill Gates, is scaling up production of a cancer drug ingredient it discovered by accident—creating revenue that could help fund its first advanced reactor in Wyoming, now delayed to 2030.
SHINE Technologies sells its fusion energy to the defense sector for up to $200K/kWh.